NCT04036500View on ClinicalTrials.gov

Transgender Estradiol

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 23, 2019

Primary Completion Date

July 13, 2020

Study Completion Date

July 13, 2020

Conditions
Transgender Persons
Interventions
DRUG

Estradiol

Patients will be given estradiol: 1 mg oral and 1 mg sublingual.

Trial Locations (1)

53226

Froedtert Hospital, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT04036500 - Transgender Estradiol | Biotech Hunter | Biotech Hunter